Stock Symbol 01177
About Us
About Sino Biopharm
Management Team
Major Events
R&D
Products
Innovative Products
Oncology
Hepatology
Respiratory
Surgery/Analgesic
Others
News
Sustainability
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Legel Terms
Our Culture
Human Development
Join Us
CN
EN
Sustainability
Home
>
Sustainability
>
ESG Dynamics
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Sino Biopharm Sets up a Production Line in Malaysia
Release Date: 2021-12-31
Share:
Previous:
Helping Developing Countries Enhance Their COVID-19 Response Capabilities
Next:
Quality Culture Construction